166 Results for "

Casein Kinase

" in MedChemExpress (MCE) Product Catalog:
Products (166)

166 Results for "Casein Kinase" in MCE Product Catalog:

1199
1199 Publications Verification
Art. -Nr.: HY-10108A
CAS. Nr.: 934389-88-5
Reinheit:  99.93%
Forschungsgebiete:  

Cancer

LY294002 hydrochloride is a potent and broad-spectrum PI3K inhibitor, with IC50 values of 0.5, 0.57, and 0.97 μM for P110α, P110δ and P110β, respectively. LY294002 hydrochloride also inhibits CK2 with an IC50 of 98 nM. LY294002 hydrochloride can be used for pancreatic cancer research .
loading...
    loading...
192
192 Cited Publications
Art. -Nr.: HY-15979
CAS. Nr.: 127243-85-0
Target:  

PKA Autophagy

Forschungsgebiete:  

Neurological Disease

H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.
loading...
    loading...
192
192 Cited Publications
Art. -Nr.: HY-15979A
CAS. Nr.: 130964-39-5
Target:  

PKA Autophagy

Forschungsgebiete:  

Others

H-89 dihydrochloride is a potent and selective inhibitor of protein kinase A (PKA) with an IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase.
loading...
    loading...
42
42 Cited Publications
Art. -Nr.: HY-14393
CAS. Nr.: 518-82-1
Reinheit:  99.25%
Synonyms: Frangula emodin
Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 (ACE2) interaction . Emodin inhibits casein kinase-2 (CK2). Anti-inflammatory and anticancer effects . Emodin is a potent selective 11β-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11β-HSD1, respectively. Emodin ameliorates metabolic disorder in diet-induced obese mice .
loading...
    loading...
15
15 Cited Publications
Art. -Nr.: HY-14394
CAS. Nr.: 17374-26-4
Reinheit:  98.54%
Synonyms: NSC 231634; Casein Kinase II Inhibitor I
Target:  

Casein Kinase

Forschungsgebiete:  

Cancer

TBB is a cell-permeable and ATP-competitive CK2 inhibitor with an IC50 of 0.15 μM for rat liver CK2.
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-10324
CAS. Nr.: 301836-43-1
Reinheit:  99.94%
Synonyms: Casein Kinase I Inhibitor
Forschungsgebiete:  

Cancer

D4476 is a potent, selective and cell-permeable inhibitor of casein kinase 1(CK1) with an IC50 value of 0.3 μM in vitro.
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-10456
CAS. Nr.: 303162-79-0
Reinheit:  99.76%
Target:  

p38 MAPK Casein Kinase Wnt

Forschungsgebiete:  

Inflammation/Immunology

TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis model .
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-15535
CAS. Nr.: 749234-11-5
Reinheit:  98.09%
Synonyms: CK2 Inhibitor; Casein Kinase II Inhibitor
Target:  

Casein Kinase

Forschungsgebiete:  

Cancer

DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.
loading...
    loading...
9
9 Cited Publications
Art. -Nr.: HY-14392
CAS. Nr.: 53-85-0
Reinheit:  99.89%
Synonyms: DRB
Target:  

CDK Apoptosis

Forschungsgebiete:  

Cancer

5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis .
loading...
    loading...
8
8 Cited Publications
Art. -Nr.: HY-15490
CAS. Nr.: 950912-80-8
Reinheit:  99.96%
Target:  

Casein Kinase

Forschungsgebiete:  

Cancer

PF-670462 dihydrochloride is a potent and selective inhibitor of casein kinase (CK1ε and CK1δ), with IC50s of 7.7 nM and 14 nM, respectively.
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-12279
CAS. Nr.: 1532533-67-7
Reinheit:  98.94%
Synonyms: TGR-1202; RP5264
Target:  

PI3K Casein Kinase

Forschungsgebiete:  

Cancer

Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib can be used for haematological malignancies reseach .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-12279C
CAS. Nr.: 1532533-78-0
Reinheit:  99.04%
Synonyms: TGR-1202 hydrochloride; RP5264 hydrochloride
Target:  

PI3K Casein Kinase

Forschungsgebiete:  

Cancer

Umbralisib (TGR-1202) hydrochloride is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib hydrochloride exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib hydrochloride can be used for haematological malignancies reseach .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P3815
CAS. Nr.: 132176-35-3
Target:  

Casein Kinase

Forschungsgebiete:  

Others

Casein Kinase 2 Substrate Peptide is a common CK2 substrate peptide. Casein Kinase 2 Substrate Peptide is synthesized with its C-terminus conjugated to 5-[(2-aminoethyl)amino]naphthalene-1-sulfonic acid (EDANS). Casein Kinase 2 Substrate Peptide can be used for protein kinase CK2 activity determination .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-108606
CAS. Nr.: 942289-87-4
Reinheit:  99.62%
Target:  

PI3K Casein Kinase

Forschungsgebiete:  

Cancer

PI-828 is a dual PI3K and casein kinase 2 (CK2) inhibitor with IC50s of 173 nM, 149 nM, and 1127 nM for p110α, CK2, and CK2α2 in lipid kinase assay, respectively .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-12470
CAS. Nr.: 1188296-52-7
Reinheit:  99.69%
Target:  

Casein Kinase

Forschungsgebiete:  

Others

PF-4800567 is a potent and selective inhibitor of casein kinase 1? (CK1?), with an IC50 of 32 nM, which is greater than 20-fold selectivity over CK1δ (IC50, 711 nM).
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-120675
CAS. Nr.: 1242422-09-8
Reinheit:  99.37%
Target:  

Casein Kinase Wnt

Forschungsgebiete:  

Cancer

SSTC3 is a casein kinase 1α (CK1α) activator (Kd = 32 nM) that inhibits WNT signaling (EC50 = 30 nM). SSTC3 exhibits minimal gastrointestinal toxicity compared to other classes of WNT inhibitors .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P1821
CAS. Nr.: 126768-94-3
Synonyms: MHP4-14
Target:  

PKC

Forschungsgebiete:  

Neurological Disease

Myelin Basic Protein (MHP4-14), a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (Km=7 μM). Myelin Basic Protein is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca 2+/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-P1821A
Synonyms: MHP4-14 TFA
Target:  

PKC

Forschungsgebiete:  

Neurological Disease

Myelin Basic Protein (MHP4-14) TFA, a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (Km=7 μM). Myelin Basic Protein TFA is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca 2+/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-115519
CAS. Nr.: 694522-87-7
Reinheit:  98.98%
Target:  

Casein Kinase

Forschungsgebiete:  

Cancer

(E/Z)-GO289 is a potent and selective casein kinase 2 (CK2) inhibitor (IC50=7 nM). (E/Z)-GO289 strongly lengthens circadian period. (E/Z)-GO289 exhibits cell type–dependent inhibition of cancer cell growth that correlated with cellular clock function .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-18758
CAS. Nr.: 868612-83-3
Target:  

TGF-β Receptor

Forschungsgebiete:  

Inflammation/Immunology Cancer

IN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and p38α mitogen-activated protein kinase (IC50=4.3 μM). IN-1130 suppresses renal fibrosis in obstructive nephropathy and blocks breast cancer lung metastasis .
loading...
    loading...